United Therapeutics Chairperson and CEO Martine Rothblatt Reports $5.54 Million Common Share Disposal
Bitget2026/10/23 20:37- United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on October 22, 2026.
- Rothblatt also exercised 9,500 stock options at $117.76 per share that day.
- The transactions left the family trusts involved holding 324,443 common shares, unchanged from before the exercise and sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: AI capital expenditure may reach 10 to 15 trillions USD in the next 10 years
Morgan Stanley stated that capital expenditure in the artificial intelligence (AI) sector could reach $10-15 trillions over the next decade.
Morgan Stanley: Apple's target price lowered to $350
Autoliv completes acquisition of MCF Safety Belts
Refining profits surge and oil prices soar; Saudi Aramco Q3 profits grow by 9% and maintains a dividend of 21.9 billions USD.
Driven by rising refining profits and oil prices, Saudi Aramco's third-quarter profits increased by 9%.
Crypto prices
More
